NO20014765D0 - Preparat ment for konservering av infektiöse, rekombinante adenoviruser - Google Patents

Preparat ment for konservering av infektiöse, rekombinante adenoviruser

Info

Publication number
NO20014765D0
NO20014765D0 NO20014765A NO20014765A NO20014765D0 NO 20014765 D0 NO20014765 D0 NO 20014765D0 NO 20014765 A NO20014765 A NO 20014765A NO 20014765 A NO20014765 A NO 20014765A NO 20014765 D0 NO20014765 D0 NO 20014765D0
Authority
NO
Norway
Prior art keywords
infectious
preservation
recombinant adenoviruses
preparation intended
preparation
Prior art date
Application number
NO20014765A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014765L (no
Inventor
Francis Blanche
Shian-Jiun Shih
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9904443A external-priority patent/FR2791999B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20014765L publication Critical patent/NO20014765L/no
Publication of NO20014765D0 publication Critical patent/NO20014765D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20014765A 1999-04-09 2001-10-01 Preparat ment for konservering av infektiöse, rekombinante adenoviruser NO20014765D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9904443A FR2791999B1 (fr) 1999-04-09 1999-04-09 Composition destinee a la conservation d'adenovirus recombinants infectieux
US13212099P 1999-04-30 1999-04-30
PCT/FR2000/000879 WO2000061726A1 (fr) 1999-04-09 2000-04-07 Composition destinee a la conservation d'adenovirus recombinants infectieux

Publications (2)

Publication Number Publication Date
NO20014765L NO20014765L (no) 2001-10-01
NO20014765D0 true NO20014765D0 (no) 2001-10-01

Family

ID=26234910

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014765A NO20014765D0 (no) 1999-04-09 2001-10-01 Preparat ment for konservering av infektiöse, rekombinante adenoviruser

Country Status (17)

Country Link
US (2) US6734008B2 (cs)
EP (1) EP1194529A1 (cs)
JP (1) JP2002541792A (cs)
KR (1) KR20020013521A (cs)
CN (1) CN1347450A (cs)
AU (1) AU778894B2 (cs)
BR (1) BR0009595A (cs)
CA (1) CA2364562A1 (cs)
CZ (1) CZ20013560A3 (cs)
HK (1) HK1045716A1 (cs)
HU (1) HUP0200821A3 (cs)
IL (2) IL145447A0 (cs)
MX (1) MXPA01010124A (cs)
NO (1) NO20014765D0 (cs)
NZ (1) NZ514731A (cs)
PL (1) PL351553A1 (cs)
WO (1) WO2000061726A1 (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569342B2 (en) 1997-12-10 2009-08-04 Sierra Molecular Corp. Removal of molecular assay interferences
CZ20013560A3 (cs) * 1999-04-09 2002-01-16 Aventis Pharma S. A. Tekutý nebo zmrazený přípravek určený k uchování rekombinantních infekčních adenovirů
PL199642B1 (pl) * 2002-11-15 2008-10-31 Inst Immunologii I Terapii Do Preparat bakteriofagowy o podwyższonej trwałości oraz zastosowanie blokowego kopolimeru tlenku etylenu i tlenku propylenu
EP1692279A4 (en) * 2003-11-19 2006-12-27 Merck & Co Inc VIRUS PREPARATIONS CONTAINING A CONSERVATIVE
CN1961961B (zh) * 2005-11-11 2010-05-26 深圳市源兴生物医药科技有限公司 一种药物制剂及其制备方法
CN103173493B (zh) * 2009-09-29 2014-09-24 成都康弘生物科技有限公司 一种含有重组腺病毒的制剂
CN103173494B (zh) * 2009-09-29 2015-02-18 成都康弘生物科技有限公司 一种含有重组腺病毒的制剂
CN102031246B (zh) * 2009-09-29 2013-09-11 成都康弘生物科技有限公司 一种含有重组腺病毒的制剂
CA3176971A1 (en) 2013-06-14 2014-12-18 Psioxus Therapeutics Limited A dosing regime and formulations for type b adenoviruses
LT3021859T (lt) 2013-10-25 2018-06-11 Psioxus Therapeutics Limited Onkolitiniai adenovirusai su heterologiniais genais
KR101845715B1 (ko) * 2015-06-03 2018-04-05 (주)제노텍 동결방지제 조성물
BR112018012179A2 (pt) 2015-12-17 2018-12-04 Psioxus Therapeutics Ltd adenovírus de grupo b que codifica um anticorpo ou fragmento de complexo anti-tcr
AU2017241777B2 (en) * 2016-03-28 2022-02-03 Ultragenyx Pharmaceutical Inc. Methods of heat inactivation of adenovirus
GB201713765D0 (en) 2017-08-28 2017-10-11 Psioxus Therapeutics Ltd Modified adenovirus
SG11201901715UA (en) 2016-08-29 2019-03-28 Psioxus Therapeutics Ltd Adenovirus armed with bispecific t cell engager (bite)
GB201801614D0 (en) 2018-01-31 2018-03-14 Psioxus Therapeutics Ltd Formulation
US20220305120A1 (en) * 2019-06-11 2022-09-29 Glaxosmithkline Biologicals Sa Mucosal vaccine formulations
CN110938603B (zh) * 2019-12-20 2022-11-22 阿吉安(福州)基因医学检验实验室有限公司 一种通用型病毒样本保存缓冲液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0831919B1 (en) * 1995-05-16 2002-10-16 TRYGGVASON, Karl Method for pharmaceutical delivery by gene therapy
FR2751343B1 (fr) * 1996-07-16 1998-12-18 Transgene Sa Procede de conservation de virus recombinants infectieux, suspension aqueuse virale et utilisation comme medicament
US6689600B1 (en) * 1998-11-16 2004-02-10 Introgen Therapeutics, Inc. Formulation of adenovirus for gene therapy
US6225289B1 (en) * 1998-12-10 2001-05-01 Genvec, Inc. Methods and compositions for preserving adenoviral vectors
CZ20013560A3 (cs) * 1999-04-09 2002-01-16 Aventis Pharma S. A. Tekutý nebo zmrazený přípravek určený k uchování rekombinantních infekčních adenovirů

Also Published As

Publication number Publication date
US7202078B2 (en) 2007-04-10
CN1347450A (zh) 2002-05-01
WO2000061726A1 (fr) 2000-10-19
CZ20013560A3 (cs) 2002-01-16
PL351553A1 (en) 2003-05-05
KR20020013521A (ko) 2002-02-20
NO20014765L (no) 2001-10-01
JP2002541792A (ja) 2002-12-10
IL145447A0 (en) 2002-06-30
HUP0200821A3 (en) 2004-11-29
US20040191909A1 (en) 2004-09-30
AU778894B2 (en) 2004-12-23
HK1045716A1 (zh) 2002-12-06
IL145447A (en) 2006-10-05
CA2364562A1 (fr) 2000-10-19
NZ514731A (en) 2004-03-26
HUP0200821A2 (hu) 2002-07-29
AU3825500A (en) 2000-11-14
US20020061592A1 (en) 2002-05-23
BR0009595A (pt) 2001-12-26
MXPA01010124A (es) 2002-06-26
US6734008B2 (en) 2004-05-11
EP1194529A1 (fr) 2002-04-10

Similar Documents

Publication Publication Date Title
NO20014765D0 (no) Preparat ment for konservering av infektiöse, rekombinante adenoviruser
EP1453536A4 (en) COMPOSITION FOR PRESERVING VIRUSES
HUP0202573A3 (en) Phenyl substituted hetercyclic compounds as herbicides, preparation and use thereof
NO986023L (no) Vannbasert, farmas°ytisk preparat
IS6256A (is) Samsetningar gegn veirum
NO20005399L (no) Farmasöytisk preparat
NO20015149D0 (no) Nytt farmasöytisk preparat
NO20015148L (no) Nytt farmasöytisk preparat
NO20011281D0 (no) Insekticid preparat
NO20025423D0 (no) FremgangsmÕte for fremstilling av Citalopram
NO20015104L (no) Nytt farmasöytisk preparat
NO20000456L (no) FremgangsmÕte for fremstilling av 1,2-dikloretan
NO20015105L (no) Nytt farmasöytisk preparat
IT1313660B1 (it) Procedimento stereoselettivo per la preparazione di endo-3-amminoazabicicloalcani.
NO20021036D0 (no) Farmasöytisk preparat
NO20011313D0 (no) Nytt preparat
IS6184A (is) Bóluefni gegn ISA veiru
NO20022541D0 (no) Fast preparat
AU3487799A (en) Improved live attenuated viruses for use as vectors or vaccines
AU2691400A (en) Virus vector
NO20014450L (no) Farmasöytisk preparat basert på polyaromatiske forbindelser
ITMI992457A0 (it) Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4-tetraidrois ochinolin-3-carbossiammide
NO20011312D0 (no) Nytt preparat
NO993689D0 (no) Medisinsk preparat
SE9902252D0 (sv) Medicinskt preparat

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application